| Clinical Study "Common" Name (formal title) | Number of enrollees | Funding source (pharma/NIH) | Year complete | Primary publication | Full study treatment protocol |
|---|---|---|---|---|---|
|
PHOTON [A Randomized, Double-Masked, Active-Controlled Phase 2/3 Study of the Efficacy and Safety of High-Dose Aflibercept in Patients With Diabetic Macular Edema] |
Total: 658 2q8: n = 167 8q12: n = 328 8q16: n = 163 |
Regeneron/Bayer NCT04429503 |
N/A | N/A |
 [Brown.AAO 2022, p6] |